| Cat |
Author |
Title |
| A1 |
Ferrario Angela |
Photodynamic therpy of murine mammary carcinoma: analysisi of dose-rate effects on tumor responsiveness, endothelial progenitor cell mobilization and SDF-1αexpression profiles |
| A2 |
Attoub Samir |
Effects of frondoside A on breast cancer cell survival, migration and invasion in vitro and on tumour growth in vivo |
| A3 |
Ainur Akilzhanova |
Mutation analysis of BRAC1 and BRCA2 genes in sporadic breast cancer patients in Kazakistan |
| A4 |
Park Kyonh Hwa |
Hypermethylation of promoter of Caveolin-1 gene is a modulation factor for Docetaxel activity in breast cancer |
| A5 |
Lee JinSun |
Promoter methylation profiles and field cancerization in histologically normal tissue adjacent to breast tumors |
| A6 |
Tinterri Corrado |
How the 70-gene tumor expression profile can assist in St. Gallen 2009 treatment recommendations in 12 Italian Hospitals |
| A7 |
Giraudi Sara |
Use in current clinical practice of 70-gene signature in early breast cancer |
| A8 |
Garanina Zinaida |
Multiplicity of benign breast lesions - Risk for breast cancer |
| A9 |
Castellano Isabella |
Androgen receptor expression correlates with mammaprint® risk profile |
| A10 |
Chun Yang |
Transcription factor SOX9 mediates anti-proliferative effect of lymphocyte T-derived microparticles in breast cancer cells |
| A11 |
Pacquola Maria Grazia |
BRCA1, BRCA2 in breast cancer: experience of Breast Unit ASL AL Tortona |
| B1 |
Bonetti Luisa |
Couple types and coping strategies: a reserach about conjoint drawing |
| B2 |
Capasso Immacolata |
Metabolic syndrome as an indicator of breast cancer risk in postmenopausal women |
| B3 |
Traila Nicola |
Role of multi-component functional foods in the complex treatment of patients with advanced breast cancer |
| C1 |
Iwuchukwu Obiukwu |
Analysis of breastlight findings in patients with biopsies |
| C2 |
Ng Daniel |
A clinical audit on the adherence of nice guideline in the diagnosisi and treatment of advanced breast cancer in City Hospital, Birmingham, United Kingdom |
| C3 |
Leesombatpaiboon Monchai |
Screening breast cancer with digital mammogram and ultrasound in Phyathai two hospitals |
| C4 |
Chirappapha Prakasit |
Predictive factors of axillary lymph node metastasis in breast cancer |
| C5 |
Checka Cristina M |
Changes in mammographic density induced by letrozole in a cohort of high risk women |
| C6 |
Kwang-Man Lee |
Normal physiologic and benign lesions with F-18 FDG avidity on PET/CT in breast cancer |
| C7 |
Nakano Shogo |
Coordinate real-time ultrasound and MRI with magnetic navigation improve localization of incidental enhancing lesions on breast MRI at second look ultrasound |
| C8 |
Antonini Cinzia |
Use of Tc-99 labelled colloidal albumin for preoperative and intraoperative localization of non palpable breast lesions |
| D1 |
Alexandrova Elena |
Breast cancer in women under 30 |
| D2 |
Kim Sung Yong |
Breast reconstruction using inframammary adipofascial (anterior rectus sheath) flap |
| D3 |
Sumrien H |
Gene expression analysisi to detect sentinel lymph node involvement. A review of our first 100 cases |
| D4 |
Biglu MH |
Iranian scientists approach to breast cancer reseraches |
| D5 |
Mulgrew Stephen |
Pedicled tram reconstruction in peripheral Hospital (without on-site palstics Unit) |
| D6 |
Siala Ali A |
Review of 22 cases of breast phyllodes tumour presented and treated at Doncaster Bassetlaw Hospitals NHS Trust |
| D7 |
Papadopulos Nikolaos |
Quality of life in patients with mastectomy followed by breast reconstruction. Methods & outcomes |
| D8 |
Myasoyedov Stanislav D |
Subcutaneous mastectomy with endoprothesis in patients with ammary gland cancer in early stages |
| D9 |
Baratelli Giorgio M |
A chylous fistula: a rare complication of the axillary dissection |
| D10 |
Mirzaei Hamid Reza |
5 year survival of breast cancer in two teaching hospitals in Tehran, Iran |
| D11 |
Ristov Mitko |
Role of the man at breast carcinoma |
| D12 |
Ku Sang Kim |
New breast cancer recurrence prognostic model using data mining: validation with other models |
| D13 |
Katsutoshi Enokido |
Nipple-sparing mastectomy for primary breast cancer |
| D14 |
Supsamutchai Chairat |
Retro-mammary endoscopic approach for removal of benign breast lump |
| D15 |
Lo Russo Marzia |
Use of new technologies in axillary dissection |
| D16 |
Poulakaki N |
Oncoplastic procedures: the effect of adjuvant treatment on patients undergoing oncoplastic procedures |
| D17 |
Rząca Marek |
Cryosurgery for Paget disease of the nipplein series of cases - an alternative to the classical treatment? |
| D18 |
Seeyoun Lee |
The prediction of non-sentinel lymph node metastasis in patinets who received neoadjuvant chemotherapy for clinically axillary lymph node metastasis |
| D19 |
Benn A-A |
Reconstruction in women over 70: a descriptive analysisi of presentation and characteristics |
| D20 |
Demetriou Georgia |
The fit elderly patient should receive appropriate treatment for their cancer |
| D21 |
Aono Toyokazu |
Surgical therapy by VATS partial lobectomy for breast cancer lung metastasis |
| D22 |
Turska-d'Amico Maria |
Radioguided occult lesion localisation (ROLL) technique in surgery |
| D23 |
Alcaide Barriga Anna |
Evaluation of the radio-guided occult lesion localization (ROLL) technique for the surgical treatment of the non-palpable breast malignant lesions |
| D24 |
Irwin Gareth |
One stage implant reconstruction following skin reducing mastectomy |
| D25 |
Sargenti Manuela |
Male breast cancer: state of the art |
| D26 |
Del Castillo Soledad |
Internal mammary nodes biopsy for tailored treatment strategies |
| D27 |
Mattar Denise |
Second sentinel lymph node biopsy |
| E1 |
Senad Secic |
Correlation between expression of nm23 protein and the protein HER-2 in invasive breast carcinoma |
| E2 |
Yoon Jung-Han |
Alpha-type 1 polarized dendric cells loaded with apoptotic allogeneic breast cancer cells can induce potent cytotoxic T lymphocytes against breast cancer |
| E3 |
Youn Hyun Jo |
Down regulation of PTEN by estrogen receptor α in breast cancer cells |
| E4 |
Hajian Sepideh |
The roles of prognostic factors on breast cancer recurrence in patients at radiation oncology ward Tehran, Iran |
| E5 |
Khoshnoud Mahmoud |
Immunohistochemistry compared to cytosol assays for detremination of estrogen receptor and prediction of the long term effect of adjuvant tamoxifen |
| E6 |
Noh Woo-Chul |
Phosphorylated-S6K1 as a prognostic factor in breast cancer by molecular subtype |
| E7 |
Fujii Kimihito |
The physiological activity of Shap-pa complex in the stroma of breast cancer |
| E8 |
Ratchaworapong Kampol |
Tumor cells evaluation in afferent lymphatic tract of sentinel lymph node in breast cancer patients |
| E9 |
Ji Young Kim |
Prediction model for non sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes |
| E10 |
Tarkowski Radoslaw |
Is angiogenesis assessed as microvessel density (MVD) suitable as prognostic factor in patients with breast cancer? |
| E11 |
Mori Miki |
Pathological feature of microinvasive breast cancer |
| E12 |
Smart Chanel E |
Immunophenotyping identifies basal-and luminal-like tumorspheres from breast cancer cell lines |
| E13 |
de Snoo Femke |
Development, validation and clinical application of an array based molecular subtyping profile for breast cancer |
| E14 |
Querzoli Patrizia |
THE 70 GENE MAMMAPRINT ™ SIGNATURE: FERRARA’S EXPERIENCE. |
| F1 |
Pietrarota Paolo |
ELIOT: a new therapeutic approach after breast conserving surgery |
| F3 |
Klaiklern Phatarachate |
A case report: intraoperative radiotherapy for breast cancer recurrence follow breast conservative therapy |
| F4 |
Vaidya Jayant S |
Single dose targeted intra-operative radiotherapy (TARGIT) for early breast cancer compared with external beam radiotherapy: first report of a randomized controlled trial (TARGIT-A) at 10 years maximum follow-up |
| G1 |
Linderholm Barbro K |
Confirmatory study maintains that patients with high VEGF not have an inferior survival provided that adjuvant tamoxifen is given for a proper time period |
| G2 |
Giardina Giovanni |
Fertility and pregnancy in young breast cancer (BC) survivors: single center experience |
| H1 |
Senad Secic |
Correlation between clinical-pathological parameters and expression immunohistochemical nm23 protein in invasive breast carcinoma |
| H2 |
Noh Woo-Chul |
Serum HER2 as a surrogate of tissue HER2 overexpression in the recurrent breast cancer |
| I1 |
Lugini Antonio |
The role of Bevacizumab combined with Letrozole in patients with HER-2 negative and ER and/or PgR>10% metastatic breast cancer after first-linechemotherapy with Paclitaxel and Bevacizumab: a multicenter experience |
| I2 |
JinSun Lee |
Clinical trial of Paclitaxel(Genexol®) combined with epirubicin for neoadjuvant chemotherapy in locally advanced breast cancer |
| I3 |
Cuzick Jack |
10 year analysis of the ATAC Trial |
HOME PAGE
Wed, 16 june 2010